Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Thrombogenicity of prothrombin complex concentrates.

¹Department of Transfusion Medicine, University of Göttingen, Germany. mkoehler@med.uni-goettingen.de

Thrombosis Research

|September 28, 1999

Summary

Thrombogenicity of prothrombin complex concentrates (PCC) is a risk, but improved quality and judicious use have decreased incidence. PCC quality is crucial, as shown by fatal events linked to a specific brand.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Sleep Position Detection for Closed-Loop Treatment of Sleep-Related Breathing Disorders.

IEEE ... International Conference on Rehabilitation Robotics : [proceedings]·2022

Same author

From Alpha Diversity to Zzz: Interactions among sleep, the brain, and gut microbiota in the first year of life.

Progress in neurobiology·2021

Same author

Diagnosis of presence and extent of deep infiltrating endometriosis by preoperative MRI-improvement of staging accuracy by expert training.

Journal of gynecology obstetrics and human reproduction·2021

Same author

Telehealth mitigates COPD disease progression compared to standard of care: a randomized controlled crossover trial.

Journal of internal medicine·2021

Same author

Survival outcome of non-small cell lung cancer patients: Comparing results between the database of the Comprehensive Cancer Center Zürich and the Epidemiological Cancer Registry Zurich and Zug.

Lung cancer (Amsterdam, Netherlands)·2020

Same author

Absence of colon as the predominant risk factor for liver fibrosis in adults requiring home parenteral nutrition.

Clinical nutrition ESPEN·2020

Area of Science:

Hematology
Pharmacology

Background:

Thrombogenicity of factor IX complex and prothrombin complex concentrates (PCC) is a known complication.
The incidence of these thromboembolic events has decreased due to improved concentrate quality and usage.
The clinical spectrum ranges from superficial thrombophlebitis to disseminated intravascular coagulation.

Purpose of the Study:

To review the risk factors and clinical spectrum of thrombogenicity associated with prothrombin complex concentrates (PCC).
To highlight the impact of PCC quality on thromboembolic adverse events.

Main Methods:

Review of clinical data and risk factors associated with PCC use.
Analysis of predisposing clinical factors, therapy factors, and PCC quality.
Examination of patient populations including hemophilia B and acquired hemostasis disorders.

Main Results:

Identified risk factors include underlying disease, clinical condition, dosing, concomitant therapy, and PCC quality.
Patients with acquired hemostasis disorders and conditions like liver disease or antithrombin deficiency face higher risks.
Large, repetitive PCC doses and certain concomitant therapies (protamine, aprotinin) increase risk.

Conclusions:

PCC quality plays a critical role in the occurrence of thromboembolic adverse events.
Judicious use and improved concentrate quality have reduced incidence.
Understanding risk factors is essential for safe PCC administration.

Related Experiment Videos